Hysensbio

10 patents currently held · Updated Nov 15, 2026

1 more in force is now held by another company

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Jun 2035

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Apr 1, 2027
The maintenance fee for Peptide (US 10,428,110) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
1 fee due Aug 20, 2027
The maintenance fee for Peptide (US 11,905,337) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Patent	Title	Status	Expires	Confidence
US 10,195,246	Use of CPNE7 for Differentiating Non-Dental Mesenchymal Stem Cells into Odontoblasts, Regenerating Dental Pulp and Treating Dentin Hypersensitivity In force Term ends Jun 5, 2035 · High confidence	In force	Term ends Jun 5, 2035	High confidence
US 10,428,110	Peptide In force Term ends Dec 12, 2037 · From the USPTO record	In force	Term ends Dec 12, 2037	From the USPTO record
US 10,844,092	Peptide for promoting regeneration of dentin or dental pulp tissue In force Term ends Feb 3, 2038 · From the USPTO record	In force	Term ends Feb 3, 2038	From the USPTO record
US 11,376,310	Pharmaceutical Composition for Preventing or Treating Dentin-Dental Pulp Diseases or Periodontal Disease Including CPNE4 Protein In force Term ends Dec 17, 2038 · High confidence	In force	Term ends Dec 17, 2038	High confidence
US 11,390,648	Novel Peptide In force Term ends Dec 17, 2038 · High confidence	In force	Term ends Dec 17, 2038	High confidence
US 11,905,337	Peptide In force Ends no later than Dec 17, 2038 · From the USPTO record	In force	Ends no later than Dec 17, 2038	From the USPTO record
US 11,452,682	Toothpaste composition for alleviating dentin hyperesthesia In force Term ends Apr 17, 2039 · From the USPTO record	In force	Term ends Apr 17, 2039	From the USPTO record
US 11,612,555	Oral Care Composition for Alleviating Dentine Hyperesthesia In force Term ends Apr 17, 2039 · High confidence	In force	Term ends Apr 17, 2039	High confidence
US 12,630,879	Compositions for Diagnosis, Prevention, or Treatment of Fatty Liver Disease In force Term ends Dec 9, 2041 · High confidence	In force	Term ends Dec 9, 2041	High confidence
US 12,551,406	Drug Mixing Unit for Syringe In force Term ends Feb 28, 2043 · High confidence	In force	Term ends Feb 28, 2043	High confidence

Also on record, not counted in the 10: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 no status recorded

List them